Skip to content

Assessing impact of vitamin D on kidney health

Evaluation of APOL1 Induction in Glomerular Parietal Epithelial Cells

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017376
Enrollment
50
Registered
2019-02-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N049- Nephrotic syndrome with unspecified morphologic changes

Interventions

Intervention1: Vitamin D receptor Activator (Calcitriol): 1. Oral administration of Tablet Calcitriol 1 ug once daily for 5 consecutive days to patients with nephrotic syndrome before undergoing renal

Sponsors

Post Graduate institute of Medical Education and Research Chandigarh India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either sex with Age between 18-65, undergoing renal biopsy for Evaluation of Nephrotic Syndrome 2. Healthy patients of either sex with Age between 18-65, posted for voluntary kidney donation surgery within a fortnight

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
APOL1 expression in glomerular parietal epithelial cells Timepoint: 1. In patients with Nephrotic syndrome: 5 days 2. In healthy voluntary kidney donors: 15 days

Secondary

MeasureTime frame
1. biochemical analysis before and after Vitamin D receptor agonist 2. Urine Protein Creatinine ratio before and after Vitamin D agonistTimepoint: 1. In patients with Nephrotic syndrome: 5 days 2. In Healthy voluntary controls: 15 days

Countries

India

Contacts

Public ContactRaja Ramachandran

Post Graduate Institute of Medical Education & Research, Chandigarh, India

drraja_1980@yahoo.co.in9216958874

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026